MetLife stock (US59156R1086): JP Morgan raises price target after Q1 earnings

MetLife released its first quarter results, outperforming Wall Street expectations on revenue and non-GAAP profit, according to StockStory as of May 2026. Despite the beat, shares dipped from $80.16 to $78.30 post-earnings. On May 12, 2026, JP Morgan maintained its Overweight rating and raised the price target from $95.00 to $96.00, according to GuruFocus as of May 12, 2026.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

MetLife: core business model

MetLife provides insurance and employee benefit programs to individuals and businesses worldwide. The company operates through segments including US, Asia, Latin America, Europe, Middle East and Africa (EMEA), and the Corporate & Other category. Its offerings encompass life insurance, annuities, accident and health insurance, and retirement and savings products. MetLife maintains a strong US presence, serving millions of customers and holding significant market share in group benefits and individual life policies.

The business model relies on premiums collected, investment income from policyholder assets, and fees from asset management. MetLife invests premiums in fixed income securities, equities, and alternatives to generate returns that support policy obligations and shareholder value. Risk management is central, with reinsurance used to mitigate exposure.

Main revenue and product drivers for MetLife

Group Benefits is a key US driver, providing dental, disability, life, accident, and vision coverage to employers. In Q1 2026, adjusted earnings in this segment contributed meaningfully to overall results. Life insurance and annuities remain core, with retail products targeted at individuals planning for retirement or protection needs. Premiums from these lines form the bulk of revenue, supplemented by investment spreads.

Internationally, Asia contributes growing premiums, particularly in Japan and China, where demand for protection products rises with economic development. The recent Q1 earnings highlighted strength in these regions, helping offset US market pressures. MetLife's dividend of $0.59 per share, with ex-date May 12, 2026, underscores cash flow stability from these drivers, per Stock Analysis as of May 2026.

Industry trends and competitive position

The US insurance sector faces interest rate volatility, regulatory scrutiny, and digital disruption. MetLife leverages scale and brand to compete with peers like Prudential and Lincoln National. Its global diversification reduces US-centric risks, appealing to investors tracking economic cycles. Recent stability in shares, up 6.33% over the past month as of May 2026 per MarketBeat as of May 2026, reflects resilience amid uncertainty.

Why MetLife matters for US investors

As a NYSE-listed bellwether, MetLife offers exposure to the $1.2 trillion US life insurance market. Its products tie into demographic trends like aging populations and workplace benefits demand. US investors value its quarterly dividends and potential for capital returns, with the stock trading at $72.50 USD on NYSE on 05/12/2026, according to ad-hoc-news as of 05/12/2026.

Conclusion

MetLife's Q1 earnings beat and JP Morgan's price target hike signal operational strength amid a post-earnings dip. Dividend continuity and global diversification support its profile. US investors monitor upcoming catalysts like rate changes and segment performance for ongoing relevance.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.